Prior work has shown that RNA-edited AZIN1 promoted cancer cell proliferation and tumor progression through restraining antizyme-mediated degradation of oncoproteins, such as ODC and cyclin D1 [2]. The gene discussed is ODC1; the disease is neoplasm.